A near miss for prostate cancer immunotherapy.
Academic Urology Unit, Royal Marsden Hospital, Sutton SM2 5PT, UK. Electronic address: chris.parker@rmh.nhs.uk.
Chris
C
Parker
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077143:Docetaxel; D006801:Humans; D000074324:Ipilimumab; D008297:Male; D064129:Prostatic Neoplasms, Castration-Resistant / Q000628:therapy*; D043823:Taxoids / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000074324:Ipilimumab; D043823:Taxoids; D000077143:Docetaxel